Product NDC: | 39822-4200 |
Proprietary Name: | rocuronium bromide |
Non Proprietary Name: | rocuronium bromide |
Active Ingredient(s): | 10 mg/mL & nbsp; rocuronium bromide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 39822-4200 |
Labeler Name: | X-GEN Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091115 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121201 |
Package NDC: | 39822-4200-2 |
Package Description: | 10 VIAL in 1 CARTON (39822-4200-2) > 5 mL in 1 VIAL (39822-4200-1) |
NDC Code | 39822-4200-2 |
Proprietary Name | rocuronium bromide |
Package Description | 10 VIAL in 1 CARTON (39822-4200-2) > 5 mL in 1 VIAL (39822-4200-1) |
Product NDC | 39822-4200 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rocuronium bromide |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20121201 |
Marketing Category Name | ANDA |
Labeler Name | X-GEN Pharmaceuticals, Inc. |
Substance Name | ROCURONIUM BROMIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |